123 related articles for article (PubMed ID: 27988326)
1. Everolimus TDM using Thermo Fisher QMS immunoassay on Indiko, Beckman DxC, AU680, and AU5800 analyzers.
Wong SH; Johnson-Davis KL; Garrison K; Rankin JD; Muhammad CS
Clin Biochem; 2017 May; 50(7-8):425-430. PubMed ID: 27988326
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of QMS everolimus assay using Indiko analyzer: comparison with an ultra-performance liquid chromatography-tandem mass spectrometry method.
Buthiau D; Bargnoux AS; Badiou S; Sutra T; Dupuy AM; Pageaux GP; Mourad G; Cristol JP
Ther Drug Monit; 2015 Apr; 37(2):275-8. PubMed ID: 25254414
[TBL] [Abstract][Full Text] [Related]
3. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
[TBL] [Abstract][Full Text] [Related]
4. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
[TBL] [Abstract][Full Text] [Related]
5. Latex-enhanced turbidimetric immunoassay for everolimus in whole blood using the Nanopia TDM everolimus assay with the JCA-BM6010 automatic analyzer.
Mori K; Kimura S; Matsui M; Suehisa E; Hidaka Y; Fukushima N
Ther Drug Monit; 2014 Oct; 36(5):677-80. PubMed ID: 25222856
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the interchangeability between the new fully-automated affinity chrome-mediated immunoassay (ACMIA) and the Quantitative Microsphere System (QMS) with a CE-IVD-certified LC-MS/MS assay for therapeutic drug monitoring of everolimus after solid organ transplantation.
Ialongo C; D'alessandro A; Sapio M; Angeloni A; Porzio O
Clin Chem Lab Med; 2023 Jan; 61(2):245-250. PubMed ID: 36330751
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
Dasgupta A; Davis B; Chow L
Ther Drug Monit; 2011 Apr; 33(2):149-54. PubMed ID: 21266941
[TBL] [Abstract][Full Text] [Related]
8. An automated nanoparticle-based homogeneous immunoassay for determining docetaxel concentrations in plasma.
Cline DJ; Zhang H; Lundell GD; Harney RL; Riaz HK; Jarrah J; Li Y; Miyazaki M; Courtney JB; Baburina I; Salamone SJ
Ther Drug Monit; 2013 Dec; 35(6):803-8. PubMed ID: 24263639
[TBL] [Abstract][Full Text] [Related]
9. Comparison of electrochemiluminescence immunoassay and latex agglutination turbidimetric immunoassay for evaluation of everolimus blood concentrations in renal transplant patients.
Akamine Y; Sato S; Kagaya H; Ohkubo T; Satoh S; Miura M
J Clin Pharm Ther; 2018 Oct; 43(5):675-681. PubMed ID: 29679392
[TBL] [Abstract][Full Text] [Related]
10. High-Sensitivity and High-Throughput Quantification of Everolimus in Human Whole Blood Using Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry.
Miyagi C; Tanaka R; Hirata K; Watanabe T; Tatsuta R; Miyamura S; Itoh H
Ther Drug Monit; 2022 Oct; 44(5):633-640. PubMed ID: 35383726
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Performance of Laboratory-Developed Liquid Chromatography-Tandem Mass Spectrometry Tests and a Food and Drug Administration-Approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus.
Schniedewind B; Meyer EJ; Christians U
Ther Drug Monit; 2020 Jun; 42(3):421-426. PubMed ID: 32427781
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Drug Monitoring of Everolimus: A Consensus Report.
Shipkova M; Hesselink DA; Holt DW; Billaud EM; van Gelder T; Kunicki PK; Brunet M; Budde K; Barten MJ; De Simone P; Wieland E; López OM; Masuda S; Seger C; Picard N; Oellerich M; Langman LJ; Wallemacq P; Morris RG; Thompson C; Marquet P
Ther Drug Monit; 2016 Apr; 38(2):143-69. PubMed ID: 26982492
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Long-Term Safety and Tolerability of Everolimus in Renal Transplant Recipients Converted From Cyclosporine.
Felipe CR; Oliveira NI; Hannun PG; de Paula MI; Tedesco-Silva H; Medina-Pestana JO
Ther Drug Monit; 2016 Feb; 38(1):64-72. PubMed ID: 26274696
[TBL] [Abstract][Full Text] [Related]
14. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study.
Schniedewind B; Niederlechner S; Galinkin JL; Johnson-Davis KL; Christians U; Meyer EJ
Ther Drug Monit; 2015 Jun; 37(3):296-303. PubMed ID: 25970506
[TBL] [Abstract][Full Text] [Related]
15. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.
Verstraete AG; Rigo-Bonnin R; Wallemacq P; Vogeser M; Schuetzenmeister A; Schmiedel C; Shipkova M
Ther Drug Monit; 2018 Feb; 40(1):59-68. PubMed ID: 29210975
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method.
Shipkova M; Rapp S; Rigo-Bonnin R; Wieland E; Peter A
Ther Drug Monit; 2017 Apr; 39(2):102-108. PubMed ID: 28125504
[TBL] [Abstract][Full Text] [Related]
17. Analytical Performance of the New Siemens Affinity Chrome-Mediated Immunoassay Everolimus Assay and Its Interchangeability With the Thermo Quantitative Microsphere System for Routine Therapeutic Drug Monitoring of Patients After Solid Organ Transplantation.
Ialongo C; Sapio M; Angeloni A
Ther Drug Monit; 2023 Apr; 45(2):217-222. PubMed ID: 36920504
[TBL] [Abstract][Full Text] [Related]
18. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the QMS® Teicoplanin Immunoassay (ThermoFisher Scientific) on Cobas® 8000 System (Roche Diagnostics) and comparison to fluorescence polarization immunoassay for the determination of teicoplanin concentrations in human plasma.
Dailly E; Fraissinet F; Deslandes G; Bouquié R; Jolliet P
J Clin Lab Anal; 2013 Mar; 27(2):96-8. PubMed ID: 23378010
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood samples.
Marinova M; Artusi C; Brugnolo L; Antonelli G; Zaninotto M; Plebani M
Clin Biochem; 2013 Nov; 46(16-17):1723-7. PubMed ID: 24012696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
